The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study-Reference-Cited by-同舟云学术

The Canadian Hypoglycemia Assessment Tool Program: Insights Into Rates and Implications of Hypoglycemia From an Observational Study

Published:2018-02 Issue:1 Volume:42 Page:11-17
ISSN:1499-2671
Container-title:Canadian Journal of Diabetes
language:en
Short-container-title:Canadian Journal of Diabetes

Author:

Aronson Ronnie,Goldenberg Ronald,Boras Damir,Skovgaard Rasmus,Bajaj Harpreet

Funder

Novo Nordisk

Merck

Boehringer Ingelheim

Regeneron

Abbott

Quintiles

ICON

GlaxoSmithKline

Medpace

Janssen

Sanofi

Bristol-Myers Squibb

AstraZeneca

Becton Dickinson

Eli Lilly

Amgen

Medtronic

Novartis

Roche

Takeda;

Pfizer

Valeant

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference24 articles.

1. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada;Canadian Diabetes Association Clinical Practice Guidelines Expert Committee;Can J Diabetes,2013

2. Impact of self-treated hypoglycaemia in type 2 diabetes: A multinational survey in patients and physicians;Brod;Curr Med Res Opin,2012

3. Increasing awareness of hypoglycaemia in patients with type 2 diabetes treated with oral agents;Barnett;Curr Med Res Opin,2013

4. Self-reported hypoglycemia and impact on quality of life and depression among adults with type 2 diabetes mellitus;Green;Diabetes Res Clin Pract,2012

5. Fear of hypoglycemia: Relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus;Irvine;Health Psychol,1992

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential associations of risk factors with severe and non‐severe hypoglycaemia: the Hypoglycaemia Assessment Tool prospective observational study in people with insulin‐treated type 1 diabetes and type 2 diabetes;Diabetes, Obesity and Metabolism;2024-06-03

2. Pharmacologic inhibition of somatostatin receptor 2 to restore glucagon counterregulation in diabetes;Frontiers in Pharmacology;2024-01-17

3. Acute emergencies in diabetes;BIDE' s Diabetes Desk Book;2024

4. Severe (level 3) hypoglycaemia occurrence in a real‐world cohort of adults with type 1 or 2 diabetes mellitus (iNPHORM, United States);Diabetes, Obesity and Metabolism;2023-09-13

5. Comparisons of Psycho-Behavioral Factors, Body Composition, and Clinical Outcomes in Adults With Type 2 Diabetes by Perceived Hypoglycemia;The Science of Diabetes Self-Management and Care;2023-09-01